Gregory M. Glenn, President, R&D at NOVAVAX INC (NVAX), sold 2,955 shares at $220.66 ($641K) on 2021-07-20, disclosed to the SEC on 2021-07-22.
Open-market sale of $641k NVAX by President, R&D. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $200.61 | 119 | $24K | 3.7% |
| 2 | $202.76 | 199 | $40K | 6.3% |
| 3 | $203.39 | 61 | $12K | 1.9% |
| 4 | $204.71 | 119 | $24K | 3.8% |
| 5 | $205.66 | 181 | $37K | 5.8% |
| 6 | $206.82 | 135 |
| $28K |
| 4.4% |
| 7 | $207.63 | 126 | $26K | 4.1% |
| 8 | $211.93 | 63 | $13K | 2.1% |
| 9 | $213.55 | 141 | $30K | 4.7% |
| 10 | $214.76 | 126 | $27K | 4.2% |
| 11 | $217.44 | 56 | $12K | 1.9% |
| 12 | $218.69 | 56 | $12K | 1.9% |
| 13 | $220.66 | 240 | $53K | 8.3% |
| 14 | $220.66 | 240 | $53K | 8.3% |
| 15 | $224.33 | 63 | $14K | 2.2% |
| 16 | $225.91 | 173 | $39K | 6.1% |
| 17 | $227.17 | 306 | $70K | 10.8% |
| 18 | $227.17 | 306 | $70K | 10.8% |
| 19 | $228.60 | 189 | $43K | 6.7% |
| 20 | $229.44 | 56 | $13K | 2.0% |
| Total | $217.07 avg | 2,955 | $641K | 100% |
| Filing → |
| NVAX | SELL | 2021-12-09 | $1.6M | — | Filing → |
| NVAX | SELL | 2021-12-02 | $3.2M | — | Filing → |
| NVAX | SELL | 2021-11-30 | $719K | — | Filing → |